Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Vaccines01:30

Cancer Vaccines

1.2K
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.2K
Vaccinations01:51

Vaccinations

52.9K
Overview
52.9K
Modern Molecular Taxonomy01:29

Modern Molecular Taxonomy

797
Advancements in molecular biology have revolutionized the identification and characterization of bacteria, with multiple methods leveraging DNA sequencing for enhanced precision. As sequencing technologies improve and costs decline, these approaches are increasingly used in clinical, environmental, and evolutionary studies.Multilocus Sequence Typing (MLST) examines several housekeeping genes, essential chromosomal genes encoding cellular functions, to distinguish strains. Approximately...
797
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

1.3K
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1.3K
Antigens Involved in Adaptive Immunity01:26

Antigens Involved in Adaptive Immunity

1.8K
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...
1.8K
History of Microbiology01:28

History of Microbiology

12.8K
Microbiology, a scientific field dedicated to the study of microorganisms, has undergone profound development since its inception in the 17th century. Its history is marked by key discoveries and technological advancements that have shaped our understanding of life at the microscopic level and transformed medicine, agriculture, and industry.Early Foundations of MicrobiologyThe early foundations of microbiology were built on groundbreaking observations and the development of pioneering...
12.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Three Graces of T cell receptor Vγ9Vδ2 chain activation.

Immunity·2025
Same author

Expanding the MR1 ligandome using chemical class-specific fragmentation and molecular networking.

bioRxiv : the preprint server for biology·2025
Same author

Mitochondria regulate MR1 protein expression and produce self-metabolites that activate MR1-restricted T cells.

Proceedings of the National Academy of Sciences of the United States of America·2025
Same author

Recognition of MR1-antigen complexes by TCR Vγ9Vδ2.

Frontiers in immunology·2025
Same author

The carbonyl nucleobase adduct M<sub>3</sub>Ade is a potent antigen for adaptive polyclonal MR1-restricted T cells.

Immunity·2024
Same author

MR1 Gene and Protein Expression Are Enhanced by Inhibition of the Extracellular Signal-Regulated Kinase ERK.

Cancer immunology research·2024

Related Experiment Video

Updated: Mar 8, 2026

Homogeneous Glycoconjugate Produced by Combined Unnatural Amino Acid Incorporation and Click-Chemistry for Vaccine Purposes
13:53

Homogeneous Glycoconjugate Produced by Combined Unnatural Amino Acid Incorporation and Click-Chemistry for Vaccine Purposes

Published on: December 19, 2020

5.5K

From Immunologically Archaic to Neoteric Glycovaccines.

Marco Cavallari1, Gennaro De Libero2

  • 1BIOSS Centre for Biological Signalling Studies, University of Freiburg, Schaenzlestrasse 18, 79104 Freiburg, Germany. marco.cavallari@bioss.uni-freiburg.de.

Vaccines
|January 31, 2017
PubMed
Summary

Bacterial polysaccharides (PS) are key vaccine targets. Conjugating PS to proteins improves immune memory, but challenges remain for certain bacteria, highlighting the need for advanced glycovaccine strategies.

Keywords:
T cell helpconjugateimmunosenescencepolysaccharideserotypevaccine

More Related Videos

Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria
06:38

Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria

Published on: December 8, 2023

1.7K
A Simple and Efficient Approach to Construct Mutant Vaccinia Virus Vectors
09:16

A Simple and Efficient Approach to Construct Mutant Vaccinia Virus Vectors

Published on: October 30, 2016

11.9K

Related Experiment Videos

Last Updated: Mar 8, 2026

Homogeneous Glycoconjugate Produced by Combined Unnatural Amino Acid Incorporation and Click-Chemistry for Vaccine Purposes
13:53

Homogeneous Glycoconjugate Produced by Combined Unnatural Amino Acid Incorporation and Click-Chemistry for Vaccine Purposes

Published on: December 19, 2020

5.5K
Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria
06:38

Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria

Published on: December 8, 2023

1.7K
A Simple and Efficient Approach to Construct Mutant Vaccinia Virus Vectors
09:16

A Simple and Efficient Approach to Construct Mutant Vaccinia Virus Vectors

Published on: October 30, 2016

11.9K

Area of Science:

  • Bacteriology
  • Immunology
  • Vaccinology

Background:

  • Bacterial polysaccharides (PS) are crucial surface antigens interacting with immune cells and antibodies for infection protection.
  • Current polysaccharide vaccines offer limited protection duration and fail to induce lasting immunological memory for some bacterial pathogens.
  • The rise of antibiotic resistance in bacteria like staphylococci, Streptococcus agalactiae, and Klebsiella necessitates novel prevention strategies.

Purpose of the Study:

  • To review the immunological mechanisms underlying the success and failure of glycovaccines.
  • To discuss advancements in developing effective polysaccharide (PS) vaccines against bacterial infections.
  • To explore strategies for generating high-affinity anti-PS antibodies for long-lasting immunity.

Main Methods:

  • Review of existing literature on polysaccharide vaccines and immunological memory.
  • Analysis of glycovaccine conjugation strategies and their impact on T helper cell stimulation.
  • Examination of challenges and successes in developing vaccines against specific bacterial pathogens.

Main Results:

  • Conjugation of PS to proteins enhances T helper cell responses and immunological memory, but protection duration is limited.
  • Certain bacterial PS, including those from staphylococci, Streptococcus agalactiae, and Klebsiella, have proven challenging for vaccine development.
  • Existing vaccines cover only a fraction of clinically relevant pneumococcal and meningococcal serotypes, indicating a significant unmet medical need.

Conclusions:

  • Glycovaccines represent a promising approach to combat bacterial infections, but further research is needed to overcome limitations.
  • Advancements in glycovaccine technology may lead to the generation of high-affinity antibodies and specific, long-lasting immunity.
  • Developing broadly protective and durable polysaccharide vaccines remains a critical goal in infectious disease prevention.